Acutaas Chemicals Limited

rs,

rat, India. February 4, 2023 To, The Listing Department, BSE LIMITED, Phiroze Jeejeebhoy Towers, Dalal Street, Fort Mumbai- 400 001 To, The Listing Department National Stock Exchange of India

8%

ontinued its growth momentum and margin expansion path, during the quarter with top line growing by 8% YoY. The growth was slower primarily due to deferred If we adjust the deferred shipments of certain

15%

o deferred If we adjust the deferred shipments of certain products. revenue, we would have grown by 15% during the quarter. intermediates business continues to deliver Pharmaceutical strong performance

Rs. 1,524

elivering a strong growth in coming quarter and for the financial year 2023.” Revenue for Q3FY23 Rs. 1,524 mn 7.9% YoY EBITDA for Q3FY23 Rs. 308 mn 2.9% YoY PAT for Q3FY23 Rs. 223 mn 14.4% YoY 4

7.9%

trong growth in coming quarter and for the financial year 2023.” Revenue for Q3FY23 Rs. 1,524 mn 7.9% YoY EBITDA for Q3FY23 Rs. 308 mn 2.9% YoY PAT for Q3FY23 Rs. 223 mn 14.4% YoY 4 Q3FY23

Rs. 308

nd for the financial year 2023.” Revenue for Q3FY23 Rs. 1,524 mn 7.9% YoY EBITDA for Q3FY23 Rs. 308 mn 2.9% YoY PAT for Q3FY23 Rs. 223 mn 14.4% YoY 4 Q3FY23 Earnings Highlights Financial High

2.9%

financial year 2023.” Revenue for Q3FY23 Rs. 1,524 mn 7.9% YoY EBITDA for Q3FY23 Rs. 308 mn 2.9% YoY PAT for Q3FY23 Rs. 223 mn 14.4% YoY 4 Q3FY23 Earnings Highlights Financial Highlights

Rs. 223

e for Q3FY23 Rs. 1,524 mn 7.9% YoY EBITDA for Q3FY23 Rs. 308 mn 2.9% YoY PAT for Q3FY23 Rs. 223 mn 14.4% YoY 4 Q3FY23 Earnings Highlights Financial Highlights ✓ Revenue from operations for Q3

14.4%

23 Rs. 1,524 mn 7.9% YoY EBITDA for Q3FY23 Rs. 308 mn 2.9% YoY PAT for Q3FY23 Rs. 223 mn 14.4% YoY 4 Q3FY23 Earnings Highlights Financial Highlights ✓ Revenue from operations for Q3FY23 gre

Rs.1,524

Earnings Highlights Financial Highlights ✓ Revenue from operations for Q3FY23 grew by 7.9% YoY to Rs.1,524mn; Sequentially revenue grew by 3.7% ✓ The Gross margin for the quarter was at 46.0% as compared

3.7%

✓ Revenue from operations for Q3FY23 grew by 7.9% YoY to Rs.1,524mn; Sequentially revenue grew by 3.7% ✓ The Gross margin for the quarter was at 46.0% as compared to 49.4% in Q3FY22 and 48.0% in Q2FY23

46.0%

% YoY to Rs.1,524mn; Sequentially revenue grew by 3.7% ✓ The Gross margin for the quarter was at 46.0% as compared to 49.4% in Q3FY22 and 48.0% in Q2FY23. ✓ EBITDA for the quarter came at Rs. 308mn up

“CAPEX – Funding The Capex will be funded through a mix of General Corporate funds of IPO proceeds, internal accruals, and debt.”

“Currently, the old plant at Ankleshwar is being demolished and the new plant will be built on this site.”

YoY Growth

2

Social

1

Governance

1

For more information please contact

1

YoY Growth

13% (13%) 1,120 1,271 Advance Intermediates EBITDA & EBITDA Margin (Rs Mn) 292 253 Chemicals PAT (Rs Mn) EBITDA EBITDA Margin PAT PAT Margin 350 300 250 200 150 100 21.2% 299 Q3FY22 230 23.0% 21.0% 220 19.0% 17.0% 210 15.0% 13.0% 200 11.0% 9.0% 190 7.0% 5.0% 180 20.2% 308 Q3FY23 13.8% 14.6% 195 Q3FY22 223 Q3FY23 19.0% 17.0% 15.0% 13.0% 11.0% 9.0% 7.0% 5.0% 7.9% 1,412 1,524 Total EPS EPS 5.7 Q3FY22 6.3 Q3FY23 7 Financial performance – 9M FY23 Revenue from Operations (Rs Mn) 9MFY22 9MFY23

YoY Growth

17% 3% 3,071 3,589 Advance Intermediates EBITDA & EBITDA Margin (Rs Mn) 695 715 Chemicals PAT (Rs Mn) EBITDA EBITDA Margin PAT PAT Margin 900 800 700 600 500 400 300 200 100 21.1% 794 9MFY22 23.0% 21.0% 19.0% 17.0% 15.0% 13.0% 11.0% 9.0% 7.0% 5.0% 580 570 560 550 540 530 520 510 500 490 480 470 460 450 440 430 420 410 400 13.5% 507 9MFY22 19.0% 818 9MFY23 14.0% 13.0% 12.0% 11.0% 10.0% 9.0% 8.0% 7.0% 6.0% 5.0% 13.1% 562 9MFY23 14% 3,766 4,304 Total EPS EPS 16.1 9MFY22 16.3 9MFY23 8 P&L Statement for Q3 & 9MFY23 Particulars (Rs. Mn) Q3FY23 Q3FY22 YoY Q2FY23 Revenue from Operations 1,524 1,412 7.9% 1,470 COGS Gross Profit Gross Margin Employee benefits expenses Other expenses Total Expenses EBITDA EBITDA Margin Depreciation and amortization PBIT Finance costs Other Income PBT Tax Expense PAT PAT Margin QoQ 3.7% -0.8% 823 700 714 698 46.0% 49.4% 128 264 108 290 1,216 1,112 0.4% 764 706 48.0% 128 297 1,189 308 299 2.9% 281 9.5% 20.2% 21.2% 0.8% 19.1% 28 253 4 9 9.6% 3.5% 257 15.0% 67 24 275

Social

➢ Zero Liquid Discharge based in-house effluent plant at Sachin Unit ➢ 80% of wastewater recycled ➢ Developing greenbelt in GIDC ➢ All the manufacturing units are ISO 9001:2015, ISO 14001:2015 certified ➢ Company’s Sachin Facility is SA 8000:2014 certified ➢ The SA8000® Standard is the leading social certification standard for factories and organizations across the globe** ➢ Occupational health and safety management system at Sachin Facility has been certified to be in compliance with ISO 45001:2018 standards by the Bureau Veritas Certification Holding SAS – UK Branch

Governance

✓ 50% of the board constitutes of independent directors ✓ Audit and NRC are headed by independent directors 1 2 3 38 Contents 6 Shareholder Information ➢ Performance highlights over the years ➢ Financials for the last three years ➢ Shareholder Information 39 Performance highlights over the years FY19-22 CAGR: 22% 249% Revenue from Operations – Growth Trends (Rs Mn) 4,270 3,240 2363 2322 FY19 FY20 FY21 FY22 30% 5,201 3,406 2385 2396 Advance Intermediates Chemicals Total 22 74 166 932 Revenue – by Business Verticals Pharma Intermediates 3% 1% Specialty Chemicals 5% 18% Revenue from Exports (Rs Mn) Share of Top Customers - FY22 53.8% 3,020 1,757 40.8% 32.4% 99% 97% 95% 83% 1,183 1,100 FY19 FY20 FY21 FY22 FY19 FY20 FY21 FY22 Top3 Top5 Top10 Note: Revenue from Operations for previous years does not include revenue from units acquired from GOL as the acquisition was completed on Mar-21. 40 Performance highlights over the years (cont’d) EBITDA and EBITDA Margins (%) (Rs Mn) EBITDA (₹ Mn) EBIT

For more information please contact

Ami Organics Limited Ernst & Young Ekta Srivastava, Company Secretary & Compliance Officer Rahul Thakur Rahul.thakur@in.ey.com cs@amiorganics.com © 2020 Ami Organics Limited, All Rights Reserved. 45